Published on : Oct 24, 2016
ALBANY, NY, Oct 24, 2016: The new research study, titled “ Regenerative Medicine Market in Japan 2016-2020,” offers a thorough analysis, highlighting the key growth prospects, limitations, and opportunities in the market. The product segmentation, challenges, and the competitive scenario of the regenerative medicine market have been discussed in the scope of the research report. According to the research study, the regenerative medicine market is expected to register a 30.0% CAGR between 2016 and 2020.
The rising number of government initiatives for creating awareness regarding the benefits of regenerative medicines and the transformation of overall regulatory framework encouraging quick approvals are some of the factors fuelling the regenerative medicine market growth. In addition, the strong pipeline of regenerative medicines and the emergence of 3D tissue bio-printers for the development of new and effective medicines are expected to offer promising opportunities for the key players in the market.
On the flip side, the high cost and the rise in the failure rate in clinical trials are projected to restrict the growth of the regenerative medicines market in Japan. In addition, the ethical concerns linked to regenerative medicines are further expected to act as a key challenge for the leading players in the market. Nonetheless, the expansion of the application base and the increasing number of strategic acquisitions and collaborations are expected to contribute extensively towards the growth of the market.
Click here to get more info with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=834764
On the basis of product type, the regenerative medicine market in Japan has been classified into tissue scaffold and cell therapy. Among these, the cell therapy segment is estimated to lead the overall market and register an impressive 37.0% CAGR between 2016 and 2020. The emergence of new products such as autologous cultured cartilage and autologous cultured epidermis and favorable regulatory framework are projected to encourage the growth of the Japan regenerative medicine market throughout the forecast period.
By application, the regenerative medicine market in Japan has been categorized into cardiovascular, dermatology, and musculoskeletal. The dermatology segment is expected to lead the market and register a healthy growth rate throughout the forecast period. The growing demand for regenerative medicines for skin grafting techniques to treat burns and wounds is the primary factor augmenting the growth of this market segment.
The regenerative medicine market in Japan is witnessing a high level of competition, thanks to the favorable government regulations. Key players in the market are focusing on research and development activities and the introduction of new technologies that will help with the therapeutics of different diseases. The prominent players operating in the regenerative medicine market in Japan include Terumo, JCR Pharmaceuticals, CellSeed, and Japan Tissue Engineering. An in-depth analysis of the company profiles has been included in the research study.
Some of the other key players included in the research study are Nikon, TOHO, Takeda, Sumitomo Dainippon, Healios, Astellas, Medical Holdings, TAKARA, Irvine scientific group, Fujifilm, Alfresa, TAKENAKA, Suzuken, Cyfuse Biomedical, Regience k. k, CMIC, EPS Gsroup, and Rohto.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]